Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of EDG-7500 in Hepatic Impairment
NCT07324616Phase 1Completed
- Start
- Jan 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of edg-7500 (3 arms). Primary endpoints: Area under the plasma concentration time-curve from time zero to the last measured concentration, Area under the plasma concentration time-curve from time zero extrapolated to infinity and 1 more. Started Jan 2026; status: completed.
02
Drugs
edg-7500
Beyond the preview
Go deeper on NCT07324616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07324616.